Strong synthetic opioids linked to poor postoperative pain experience

The use of powerful synthetic opioids, such as sufentanil and remifentanil, during surgery is linked to a subsequent poor ‘pain experience’—a composite of emotional, cognitive, and physical aspects of pain- suggests research published in the open access journal Regional Anesthesia & Pain Medicine.

FUJIFILM Irvine Scientific offers expanded capabilities of Presagen’s Life Whisperer Platform to aid with clinical decision-making in IVF

Genetics AI-based software module added to provide objective scoring of embryo genetic integrity and likelihood of clinical pregnancy.

June 24, 2023

Cannabis Market Shows Mixed Action in September

As we described in a previous article, the Global Cannabis Stock Index rallied for the third consecutive month, creating the first quarterly advance since 2021-Q1. That index is

October 1, 2023

Amazon’s head of health services shares why consumers could be a disruptive force to the healthcare industry

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) After years of secretive projects, leaked internal

October 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.